BioCryst Pharmaceuticals, Inc. Email Format

Biotechnology ResearchNorth Carolina, United States501-1000 Employees

BioCryst Pharmaceuticals is a commercial-stage biotechnology company focused on developing therapies for hereditary angioedema and other rare diseases. It applies structure-guided drug design to create first-in-class or best-in-class oral small-molecule medicines and injectable protein therapeutics. The company conducts research at its Discovery Center of Excellence in Birmingham, Alabama, and maintains its global headquarters in Durham, North Carolina, with a regional office in Boston, Massachusetts, and operations spanning multiple countries.

BioCryst serves patients and healthcare providers seeking new options for management of HAE and other rare conditions. It positions itself as a research-driven organization within biotechnology, translating structural design insights into potential therapies. In April 2026, BioCryst announced the appointment of Sandeep M. Menon as Chief Research and Development Officer.

Sign up for free to view info

Company overview Employee directory